CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Accumulated Deficit
Balance, beginning of period at Feb. 01, 2020	$ 76,955	$ 172,885	$ (95,930)
Balance, beginning of period (in shares) at Feb. 01, 2020		13,955,826
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Employee stock purchases	35	$ 35
Employee stock purchases (in shares)		34,999
Exercise of stock options	360	$ 360
Exercise of stock options (in shares)		52,561
Restricted stock issued		281,604
Net share settlement of stock options and restricted stock units	(60)	$ (60)
Net share settlement of stock options and restricted stock units (in shares)		(22,814)
Stock-based compensation expense	1,171	$ 1,171
Repurchase and retirement of common stock	$ (178)		(178)
Repurchase and retirement of common stock (in shares)	(9,926)	(9,926)
Net (loss) income	$ 16,639		16,639
Balance, end of period at Jan. 30, 2021	94,922	$ 174,391	(79,469)
Balance, end of period (in shares) at Jan. 30, 2021		14,292,250
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options	177	$ 177
Exercise of stock options (in shares)		49,454
Restricted stock issued		120,468
Net share settlement of stock options and restricted stock units	(379)	$ (379)
Net share settlement of stock options and restricted stock units (in shares)		(21,504)
Stock-based compensation expense	1,667	$ 1,667
Repurchase and retirement of common stock	$ (37,287)		(37,287)
Repurchase and retirement of common stock (in shares)	(1,809,321)	(1,809,321)
Net (loss) income	$ 22,026		22,026
Balance, end of period at Jan. 29, 2022	$ 81,126	$ 175,856	(94,730)
Balance, end of period (in shares) at Jan. 29, 2022	12,631,347	12,631,347
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options	$ 16	$ 16
Exercise of stock options (in shares)		2,705
Restricted stock issued		826,423
Net share settlement of stock options and restricted stock units	(2,383)	$ (2,383)
Net share settlement of stock options and restricted stock units (in shares)		(226,141)
Stock-based compensation expense	1,961	$ 1,961
Repurchase and retirement of common stock	$ (6,253)		(6,253)
Repurchase and retirement of common stock (in shares)	(479,966)	(479,966)
Net (loss) income	$ (44,694)		(44,694)
Balance, end of period at Jan. 28, 2023	$ 29,773	$ 175,450	$ (145,677)
Balance, end of period (in shares) at Jan. 28, 2023	12,754,368	12,754,368